Sitagliptin Better for Glycemic Control in T2D With Renal Impairment
Study results indicated that sitagliptin showed greater glycemic efficacy than dapagliflozin treatment.
Jennifer Mannheim
Assistant Editor https://www.renalandurologynews.com
Jennifer Mannheim is an assistant editor for the Haymarket Medical Network. She graduated from Montclair State University with a degree in Psychology.
